Clinical Web Archive

Sign in Subscribe

Nephrology

Effects of Aliskiren Monotherapy on Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Blood Pressure and Urinary Protein Excretion Outcomes.

Quick Take: Aliskiren offers a sustained antiproteinuric effect in CKD, potentially useful for ACEi/ARB-intolerant patients, but its blood pressure-lowering is transient, demanding cautious consideration due to limited long-term evidence. 💡 Clinical Impact * Provides a potential alternative for managing proteinuria in chronic kidney disease patients who cannot tolerate standard ACE inhibitor

Prevention of urinary stones with hydration: a randomised clinical trial of an adherence intervention.

Quick Take: Implementing targeted hydration adherence strategies significantly reduces the recurrence of urinary stones. 💡 Clinical Impact * Offers a non-pharmacological, patient-centric approach to mitigate a common, painful, and recurrent nephrologic condition, potentially improving long-term patient quality of life. * Provides a practical, evidence-backed intervention that can be integrated into routine stone prevention